Last year was a complete success for many investors - but not for everyone. While the S&P 500 rose by around 25 %, there were also shares that took a nosedive. 🤔

The biggest losers included companies such as Celanese Corp. $CE (+1,26%), which fell by 19.25 %, and Estée Lauder ($EL (-0,66%)which lost 1.45 %. Intel $INTC (+28,32%) and Moderna $MRNA (+2,33%) were also under pressure.

But what does that mean? Are yesterday's flops the potential stars of tomorrow? Some analysts see recovery potential, while others point to the ongoing challenges.

What do you think? Is it worth buying into these supposed bargains now, or is staying away the better strategy? Let's discuss it! 📈💬